AllianceBernstein’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.1M Sell
888,035
-64,030
-7% -$5.07M 0.02% 496
2025
Q4
$74.1M Buy
952,065
+903,296
+1,852% +$61M 0.02% 509
2025
Q3
$2.76M Buy
48,769
+1,729
+4% +$78K ﹤0.01% 1821
2025
Q2
$2.05M Buy
47,040
+2,050
+5% +$70.6K ﹤0.01% 1919
2025
Q1
$1.23M Sell
44,990
-43,256
-49% -$1.58M ﹤0.01% 2135
2024
Q4
$3.55M Sell
88,246
-36,368
-29% -$1.64M ﹤0.01% 1658
2024
Q3
$5.9M Buy
124,614
+30,946
+33% +$1.37M ﹤0.01% 1451
2024
Q2
$2.8M Sell
93,668
-8,435
-8% -$292K ﹤0.01% 1767
2024
Q1
$4.1M Buy
102,103
+63,703
+166% +$2.28M ﹤0.01% 1549
2023
Q4
$978K Buy
38,400
+400
+1% +$7.15K ﹤0.01% 2282
2023
Q3
$528K Hold
38,000
﹤0.01% 2546
2023
Q2
$874K Hold
38,000
﹤0.01% 2347
2023
Q1
$1.13M Hold
38,000
﹤0.01% 2169
2022
Q4
$948K Hold
38,000
﹤0.01% 2312
2022
Q3
$827K Hold
38,000
﹤0.01% 2398
2022
Q2
$748K Sell
38,000
-23,614
-38% -$552K ﹤0.01% 2498
2022
Q1
$2.61M Buy
61,614
+24,914
+68% +$1.05M ﹤0.01% 1936
2021
Q4
$2.33M Hold
36,700
﹤0.01% 2044
2021
Q3
$2.16M Sell
36,700
-900
-2% -$52.2K ﹤0.01% 2125
2021
Q2
$1.82M Buy
37,600
+26,800
+248% +$1.16M ﹤0.01% 2250
2021
Q1
$420K Buy
10,800
+4,000
+59% +$241K ﹤0.01% 2744
2020
Q4
$422K Buy
+6,800
New +$332K ﹤0.01% 2663

Other funds holding KYMR